Tango Therapeutics Statistics
Total Valuation
TNGX has a market cap or net worth of $141.62 million. The enterprise value is -$38.16 million.
Important Dates
The next confirmed earnings date is Monday, May 12, 2025, before market open.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TNGX has 108.11 million shares outstanding. The number of shares has increased by 10.24% in one year.
| Current Share Class | 108.11M |
| Shares Outstanding | 108.11M |
| Shares Change (YoY) | +10.24% |
| Shares Change (QoQ) | +1.49% |
| Owned by Insiders (%) | 1.54% |
| Owned by Institutions (%) | 44.07% |
| Float | 46.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.51 |
| Forward PS | 5.18 |
| PB Ratio | 0.85 |
| P/TBV Ratio | 0.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.26, with a Debt / Equity ratio of 0.22.
| Current Ratio | 6.26 |
| Quick Ratio | 6.03 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -61.35% and return on invested capital (ROIC) is -36.01%.
| Return on Equity (ROE) | -61.35% |
| Return on Assets (ROA) | -26.79% |
| Return on Invested Capital (ROIC) | -36.01% |
| Return on Capital Employed (ROCE) | -61.19% |
| Revenue Per Employee | $264,452 |
| Profits Per Employee | -$853,316 |
| Employee Count | 155 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TNGX has paid $202,000 in taxes.
| Income Tax | 202,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.56% in the last 52 weeks. The beta is 1.03, so TNGX's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | -81.56% |
| 50-Day Moving Average | 1.53 |
| 200-Day Moving Average | 4.67 |
| Relative Strength Index (RSI) | 45.83 |
| Average Volume (20 Days) | 579,602 |
Short Selling Information
The latest short interest is 12.55 million, so 11.61% of the outstanding shares have been sold short.
| Short Interest | 12.55M |
| Short Previous Month | 11.24M |
| Short % of Shares Out | 11.61% |
| Short % of Float | 26.76% |
| Short Ratio (days to cover) | 19.09 |
Income Statement
In the last 12 months, TNGX had revenue of $40.99 million and -$132.26 million in losses. Loss per share was -$1.21.
| Revenue | 40.99M |
| Gross Profit | -102.93M |
| Operating Income | -145.87M |
| Pretax Income | -116.32M |
| Net Income | -132.26M |
| EBITDA | -143.37M |
| EBIT | -145.87M |
| Loss Per Share | -$1.21 |
Full Income StatementBalance Sheet
The company has $216.72 million in cash and $36.95 million in debt, giving a net cash position of $179.78 million or $1.66 per share.
| Cash & Cash Equivalents | 216.72M |
| Total Debt | 36.95M |
| Net Cash | 179.78M |
| Net Cash Per Share | $1.66 |
| Equity (Book Value) | 166.76M |
| Book Value Per Share | 1.55 |
| Working Capital | 189.01M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$135.34 million and capital expenditures -$610,000, giving a free cash flow of -$135.95 million.
| Operating Cash Flow | -135.34M |
| Capital Expenditures | -610,000 |
| Free Cash Flow | -135.95M |
| FCF Per Share | -$1.26 |
Full Cash Flow StatementMargins
| Gross Margin | -251.11% |
| Operating Margin | -355.87% |
| Pretax Margin | -322.18% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |